In multiple myeloma, for instance, Dickkopf-1 (DKK1), an inhibitor of WNT-receptor-interaction, secreted by myeloma cells takes a key role in formation of osteolytic lesions by inhibiting osteoblast differentiation [96,97]. Here, DKK1 is linked to plasma cell myeloma.